Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits - Wikidata - awgldk - TriplyDB

Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits

Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits

http://www.wikidata.org/entity/Q24679813

about

Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?Antibodies in celiac disease: implications beyond diagnostics.Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits ACG clinical guidelines: diagnosis and management of celiac disease Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study.Predictors of family risk for celiac disease: a population-based study Intestinal intraepithelial lymphocyte cytometric pattern is more accurate than subepithelial deposits of anti-tissue transglutaminase IgA for the diagnosis of celiac disease in lymphocytic enteritis.Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease.Clinical utility of celiac disease-associated HLA testing Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity.Intestinal-mucosa anti-transglutaminase antibody assays to test for genetic gluten intolerance.The changing clinical profile of celiac disease: a 15-year experience (1998-2012) in an Italian referral center The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease.Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland.Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase.Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease.Type 1 diabetes is associated with enterovirus infection in gut mucosa Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease.Diagnostic immunology in celiac disease.Coeliac disease--a diagnostic and therapeutic challenge.What is the use of biopsy and antibodies in coeliac disease diagnosis?An update on the diagnostics of celiac disease.Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.Noncoeliac enteropathy: the differential diagnosis of villous atrophy in contemporary clinical practice.The adaptive immune response in celiac disease.The intestinal B-cell response in celiac disease.Non-celiac wheat sensitivity as an allergic condition: personal experience and narrative review.Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review.Seronegative celiac disease: where is the specific setting?Novel diagnostic techniques for celiac disease.Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.Non-coeliac gluten/wheat sensitivity: advances in knowledge and relevant questions.Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease.Latent coeliac disease or coeliac disease beyond villous atrophy?Transglutaminase 2 in human diseases.Celiac Disease: Diagnostic Standards and Dilemmas.Altered Esophageal Mucosal Structure in Patients with Celiac Disease.

P2860

Q26786935-718DD779-EBC6-42AF-BEC9-B54004AD5A31 Q27693707-7A33D6DD-2DD6-404F-9408-FA309D0D15E9 Q33321946-9C02D1FE-0FDA-443C-AEFD-42116C8FCAE4 Q33457749-5CB4870D-C19A-41F3-892D-E1B7B33DE292 Q33475246-5A90DD2C-7216-4171-BE0C-C83B6B0AAF06 Q33696829-CD6FF4A5-833C-4460-8027-55229CFE09C7 Q33881583-6AAB8831-DC14-4FF6-A830-DC7402A3BFD2 Q34083093-553DBE11-7FCE-4AA6-ADB1-CD6C638761C7 Q34110718-C84FE1A2-07D1-417D-AC5B-90D1851911FF Q34289847-40C3C2FD-23A7-49C7-9EA7-BD0EFF39071C Q34455608-DDB0A480-89C8-4DC8-A336-30A33CD4FF4E Q34539509-49353073-A7A2-47A7-9371-A06020314748 Q34616316-EBF1C730-25FA-4740-BC3B-F96C8BD55A39 Q34628762-DBFE53D7-CA55-4A8A-BA29-763599136E2C Q34840874-4A8C9AE4-980C-4568-95D7-B9EB982CE1EA Q35082964-B7006EE5-3E40-4BB2-9538-F44E8ED68EB0 Q35685749-8939FF44-EE0A-4DD9-A3F1-48BC96DB0219 Q35766884-9D51ECD6-94F2-4DFD-976B-BE56030DE831 Q36449613-F626CBE4-26A7-40C4-A462-64D4001E7E38 Q37548310-D25A556F-7BAB-4978-B32C-AB230B01AD53 Q37754699-0B5BEDC4-3BBE-401B-8DC0-BDDC783E26FA Q37767725-1F207BD6-7438-4C42-81A0-40665FFEC4BA Q37858601-B2D50275-AB32-488B-8319-85971299BF48 Q37905041-AB0D7AEC-61B3-44C2-86C3-16F727B3CA0B Q37931041-9F0C79F1-F16D-4600-8CF5-515844D6AC1A Q37965215-4D34AFB4-63B6-4898-B736-FC0402EA2EC3 Q38005620-8DBBC1C9-3465-418A-A486-5A125991BD9B Q38051635-691B468F-F812-4671-AA59-42A6FE48BE8A Q38156292-77F42DC4-EA97-4F7F-9BE4-8B316D2B2517 Q38364232-4947D264-B305-4B76-8FBB-CD12474D8FFC Q38450842-A26699CF-1041-4892-B55B-541A9A0FFB97 Q38720803-020F2513-83FB-4CD9-B2CD-49AD8508A7F0 Q38855195-B762DE96-01E4-42F0-80A8-F4686522CD81 Q38883608-53CA2E71-27B0-4F8D-BF0E-FC6E643D80A0 Q39010250-CC0E0542-6F3A-4D73-AC5A-D624FA07D912 Q39280266-A9F8CD17-4854-40AE-895F-8BBFF380616C Q41110454-BA9399BE-85F6-4730-842E-6752B8C12362 Q41521275-79C1888F-D315-45A1-A92B-2183D9B86EC4 Q41810194-39C9E397-A483-4612-8B9C-6D1A9040CED1 Q42155477-169FD064-5281-4602-A81C-0A9B4D3BD073

P2860

Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits

http://www.wikidata.org/entity/Q24679813

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Endomysial antibody-negative c ...... testinal autoantibody deposits

@ast

Endomysial antibody-negative c ...... testinal autoantibody deposits

@en

Endomysial antibody-negative c ...... testinal autoantibody deposits

@nl

type

label

Endomysial antibody-negative c ...... testinal autoantibody deposits

@ast

Endomysial antibody-negative c ...... testinal autoantibody deposits

@en

Endomysial antibody-negative c ...... testinal autoantibody deposits

@nl

prefLabel

Endomysial antibody-negative c ...... testinal autoantibody deposits

@ast

Endomysial antibody-negative c ...... testinal autoantibody deposits

@en

Endomysial antibody-negative c ...... testinal autoantibody deposits

@nl

P1433

Q24679813-53CE2CE2-B97F-4624-A6E3-066F7881358E

P1476

Q24679813-9389E455-FD95-4599-A07E-B1E0CDC22043

P2093

Q24679813-00B199BE-AF2D-40D8-ACBE-21F86B6A39B3

Q24679813-16FAE04D-4EFF-4263-850B-C553EBD21C30

Q24679813-34CA06FD-35EE-4E13-B21A-A8EAB57274F3

Q24679813-38EE5137-85C4-434A-B8B9-F6722E04A77E

Q24679813-38F077A2-4B90-479F-B745-C03A96B3EFDE

Q24679813-3C8DF412-18A1-4DE4-A5A6-65EB14BC18FC

Q24679813-5D607E82-EFF5-4475-9591-38AE2FB6C948

Q24679813-80A0CB47-D0DB-4D11-85D9-9B39B4FF8D21

Q24679813-C6B6663A-E70B-47BB-9AA9-AE6BA0E95BB6

Q24679813-F43F9956-B61C-48F0-B84C-F4033DF44BD1

P2860

Q24679813-0226AACA-EBC7-4890-9F0A-B951B6C4BA2B

Q24679813-141A9538-6178-4E6B-A7E6-237B66220707

Q24679813-25AAC745-BDB1-42C1-B2DD-FA434A31DE3C

Q24679813-29950DB0-A838-45F2-8EAA-780D4023D238

Q24679813-44A5D1D5-A033-4E15-B5B6-545C037E5943

Q24679813-44DCBCD3-C862-4506-A698-8FD796398E01

Q24679813-64A7B34B-B0F8-4832-8DC2-3B2435534DEF

Q24679813-69229CBD-3862-4806-8B35-F207721A9444

Q24679813-6BB244CF-0574-4183-ABF7-F95C493D1B8C

Q24679813-7305A208-BA10-4483-A8A8-F754B2C6C56E

P304

Q24679813-8CD783BD-B6BA-4D88-94F0-A23CD9560DEC

P31

Q24679813-656FDF27-6746-42D6-A072-B482290A5DBE

P356

Q24679813-3F34E26F-1C6D-4210-9CC0-E0FACDA69067

P407

Q24679813-7E359B9B-9022-40D4-8FBA-2E7E27281C62

P433

Q24679813-F27B2C61-E061-4094-859F-A347D7935B47

P478

Q24679813-4825B7C4-5C20-445A-9D5F-C383A12DF083

P50

Q24679813-E63014D8-BAA5-4E02-8339-28E19E5E17A7

P577

Q24679813-02076A08-6091-49C9-98E5-2C9782CE8D3B

P5875

Q24679813-93F201BF-D83E-4CD9-9C93-EE6C5B16FA4E

P698

Q24679813-9D4C411E-599D-4C47-9775-957759251742

P921

Q24679813-286B06BB-01A3-4FFF-9A19-6C4C97CD9F3F

Q24679813-64751BA2-E3CA-442B-ADFF-6F56BC19CC74

Q24679813-D645FE27-199A-4682-A3E7-B0DACA54AF06

P932

Q24679813-F2945378-D454-4A18-8839-3863B022835E

P356

GUT.2005.071514

P1433

P1476

Endomysial antibody-negative c ...... testinal autoantibody deposits

@en

P2093

H Huhtala

http://www.w3.org/2001/XMLSchema#string

I R Korponay-Szabó

http://www.w3.org/2001/XMLSchema#string

K Kaukinen

http://www.w3.org/2001/XMLSchema#string

K Laurila

http://www.w3.org/2001/XMLSchema#string

L Lorand

http://www.w3.org/2001/XMLSchema#string

M Mäki

http://www.w3.org/2001/XMLSchema#string

P Collin

http://www.w3.org/2001/XMLSchema#string

R Király

http://www.w3.org/2001/XMLSchema#string

T Reunala

http://www.w3.org/2001/XMLSchema#string

T T Salmi

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of tissue transglutaminase as the autoantigen of celiac disease

Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease.

Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth.

Association of a transglutaminase-related antigen with intermediate filaments.

Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma.

Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac sprue.

Intestinal antibody pattern of coeliac disease: association with gamma/delta T cell receptor expression by intraepithelial lymphocytes, and other indices of potential coeliac disease.

Endomysium antibodies in coeliac disease: an improved method.

Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.

Prevalence of Celiac disease among children in Finland.

P304

1746-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.071514

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7207070

http://www.w3.org/2001/XMLSchema#string

P698

16571636

http://www.w3.org/2001/XMLSchema#string

P921

P932

1856451

http://www.w3.org/2001/XMLSchema#string